CARBOSORB XS activated charcoal 50 g/250 mL and sorbitol 70.75 g/250 mL suspension bottle Australia - English - Department of Health (Therapeutic Goods Administration)

carbosorb xs activated charcoal 50 g/250 ml and sorbitol 70.75 g/250 ml suspension bottle

phebra pty ltd - activated charcoal, quantity: 0.2 g/ml; sorbitol, quantity: 0.283 g/ml - suspension - excipient ingredients: propylene glycol; citric acid; sodium hydroxide; glycerol; purified water - for the treatment of poisoning and drug overdosage by oral ingestion.

ARAMINE metaraminol (as tartrate) 10 mg/1 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

aramine metaraminol (as tartrate) 10 mg/1 ml injection vial

phebra pty ltd - metaraminol tartrate, quantity: 18.96 mg (equivalent: metaraminol, qty 10 mg) - injection - excipient ingredients: sodium metabisulfite; sodium chloride; water for injections; sodium hydroxide; tartaric acid - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma.,it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

RETINOFLUOR fluorescein sodium 25% injection Australia - English - Department of Health (Therapeutic Goods Administration)

retinofluor fluorescein sodium 25% injection

phebra pty ltd - fluorescein sodium, quantity: 250 mg/ml - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - indications as at 01 january 1991 : diagnostic - intravenous injection of sodium fluorescein dye followed by multiframe photography (angiography) or ophthalmoscopic evaluation (angioscopy). used in evaluation of wide range of retinal and choroidal diseases. less commonly used to evaluate abnormalities of the optic nerve and iris. may be used in diagnosis and management of macular and vascular (including diabetes) diseases.

RETINOFLUOR fluorescein sodium 10% injection 1g/10mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

retinofluor fluorescein sodium 10% injection 1g/10ml vial

phebra pty ltd - fluorescein sodium, quantity: 100 mg/ml - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - indications as at 01 january 1991 : diagnostic - intravenous injection of sodium fluorescein dye followed by multiframe photography (angiography) or ophthalmoscopic evaluation (angioscopy). used in evaluation of wide range of retinal and choroidal diseases. less commonly used to evaluate abnormalities of the optic nerve and iris. may be used in diagnosis and management of macular and vascular (including diabetes) diseases.

QUININE DIHYDROCHLORIDE 6% sterile concentrate (600 mg/10 mL) injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

quinine dihydrochloride 6% sterile concentrate (600 mg/10 ml) injection vial

phebra pty ltd - quinine dihydrochloride, quantity: 60 mg/ml - injection, solution - excipient ingredients: water for injections - indications as at 1 january 1991 : acute treatment of malaria. it may also be used in the treatment of babesiosis in conjunction with clindamycin.

SYNTOMETRINE oxytocin / ergometrine maleate 1mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

syntometrine oxytocin / ergometrine maleate 1ml injection ampoule

phebra pty ltd - oxytocin, quantity: 5 iu; ergometrine maleate, quantity: 0.5 mg - injection, solution - excipient ingredients: sodium chloride; maleic acid; water for injections; acetic acid; sodium acetate trihydrate; chlorobutanol hemihydrate - active management of the third stage of labour. prevention and treatment of post-partum haemorrhage associated with uterine atony.

BREVIBLOC esmolol hydrochloride 2.5 g powder for injection for infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

brevibloc esmolol hydrochloride 2.5 g powder for injection for infusion vial

phebra pty ltd - esmolol hydrochloride, quantity: 2500 mg - injection, powder for - excipient ingredients: - supraventricular tachycardia,brevibloc (esmolol hcl) is indicated for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. brevibloc is also indicated in non compensatory sinus tachycardia where, in the physician's judgement, the rapid heart rate requires specific intervention. brevibloc is not intended for use in chronic settings where transfer to another agent is anticipated or for treatment periods greater than 24 hours duration.

BENZTROP benztropine mesilate 2mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

benztrop benztropine mesilate 2mg tablet bottle

phebra pty ltd - benzatropine mesilate, quantity: 2 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; pregelatinised maize starch; microcrystalline cellulose; magnesium stearate - indicated for the treatment of all forms of parkinsonism. the treatment of extrapyramidal reactions (except tardive dyskinesia [see contraindications and precautions]) due to neuroleptic drugs.

ARGININE HYDROCHLORIDE 60% INJECTION (15g/25mL) vial Australia - English - Department of Health (Therapeutic Goods Administration)

arginine hydrochloride 60% injection (15g/25ml) vial

phebra pty ltd - arginine hydrochloride, quantity: 600 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections - indications as at 01 jan 1991 : arginine stimulates the release of growth hormone by the pituitary gland and may be used instead of , or in addition to, other tests such as insulin-induced hypoglycaemia, for the evaluation of growth disorders; false positive and false negative results are relatively common and evaluation therefore should not be made on the basis of a single arginine test. arginine is used as an acidifying agent in severe metabolic alkalosis. arginine is used in some conditions accompanied by hyperammonaemia stemming from inborn errors of the urea cycle, particularly where there is a severe deficiency of ornithine carbamoyl transferase or carbamoyl phosphate synthetase where respiratory alkalosis is present.

ZINC CHLORIDE 10.6mg/2mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

zinc chloride 10.6mg/2ml concentrated injection vial

phebra pty ltd - zinc chloride, quantity: 5.3 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid - indications as at 01 jan 1991 : zinc chloride injection is intended for use as an additive to compatible intravenous fluids or total parenteral nutrition solutions. it is indicated for the prevention and treatment of zinc deficiency, which may be characterised by growth deterioration, skin lesions, alopecia, impaired reproductive development and function, and delayed or inhibited wound healing. indications as at 01 jan 1991 : zinc chloride injection is intended for use as an additive to compatible intravenous fluids or total parenteral nutrition solutions. it is indicated for the prevention and treatment of zinc deficiency, which may be characterised by growth deterioration, skin lesions, alopecia, impaired reproductive development and function, and delayed or inhibited wound healing.